High sensitivity troponin-I threshold to predict perioperative myocardial infarction.
Journal
Journal of cardiothoracic surgery
ISSN: 1749-8090
Titre abrégé: J Cardiothorac Surg
Pays: England
ID NLM: 101265113
Informations de publication
Date de publication:
17 Jul 2023
17 Jul 2023
Historique:
received:
17
07
2022
accepted:
28
06
2023
medline:
19
7
2023
pubmed:
18
7
2023
entrez:
17
7
2023
Statut:
epublish
Résumé
High-sensitivity Troponin I (hs-cTnI) has largely replaced conventional troponin assays in an effort to improve detection of myocardial infarction. However, the mean displacement of hs-cTnI following coronary artery bypass graft (CABG) and the optimal threshold to detect perioperative myocardial infarction (MI) is unclear. Our objective is to describe mean hs-cTnI values at 6-12 h post-CABG and to determine the highest specificity while maintaining 100% sensitivity hs-cTnI cut-off values for diagnosis of perioperative or type-5 MI. Between 2016 and 2018, 374 patients underwent non-emergent, isolated CABG. Pre-operative and 6 h post-operative hs-cTnI values were recorded as well as ECG, echocardiographic and angiographic data. Of 374 patients, 151 (40.3%) had normal and 224 (59.7%) had elevated preoperative hs-cTnI. Patients with normal preoperative hs-cTnI had a mean 6 h hs-cTnI of 9193 ng/l or 270X the upper normal value. Eleven patients (7.3%) presented with post-operative MI with a mean 6 h hs-cTnI of 50,218 ng/l or 1477X the upper normal value. Patients with elevated preoperative hs-cTnI had a mean 6 h hs-cTnI of 9449 ng/l or 292X the upper normal value. Eleven patients (4.9%) who presented with post-operative MI had a mean 6 h hs-cTnI of 26,823 ng/l or 789X the upper normal value. We suggest hs-cTnI threshold of 80-fold in patients with normal pre-operative hs-cTnI and 2.7-fold in patients with elevated pre-operative hs-cTnI. These results have important implications for perioperative care and for surgical trial reporting.
Sections du résumé
BACKGROUND
BACKGROUND
High-sensitivity Troponin I (hs-cTnI) has largely replaced conventional troponin assays in an effort to improve detection of myocardial infarction. However, the mean displacement of hs-cTnI following coronary artery bypass graft (CABG) and the optimal threshold to detect perioperative myocardial infarction (MI) is unclear. Our objective is to describe mean hs-cTnI values at 6-12 h post-CABG and to determine the highest specificity while maintaining 100% sensitivity hs-cTnI cut-off values for diagnosis of perioperative or type-5 MI.
METHODS
METHODS
Between 2016 and 2018, 374 patients underwent non-emergent, isolated CABG. Pre-operative and 6 h post-operative hs-cTnI values were recorded as well as ECG, echocardiographic and angiographic data.
RESULTS
RESULTS
Of 374 patients, 151 (40.3%) had normal and 224 (59.7%) had elevated preoperative hs-cTnI. Patients with normal preoperative hs-cTnI had a mean 6 h hs-cTnI of 9193 ng/l or 270X the upper normal value. Eleven patients (7.3%) presented with post-operative MI with a mean 6 h hs-cTnI of 50,218 ng/l or 1477X the upper normal value. Patients with elevated preoperative hs-cTnI had a mean 6 h hs-cTnI of 9449 ng/l or 292X the upper normal value. Eleven patients (4.9%) who presented with post-operative MI had a mean 6 h hs-cTnI of 26,823 ng/l or 789X the upper normal value.
CONCLUSIONS
CONCLUSIONS
We suggest hs-cTnI threshold of 80-fold in patients with normal pre-operative hs-cTnI and 2.7-fold in patients with elevated pre-operative hs-cTnI. These results have important implications for perioperative care and for surgical trial reporting.
Identifiants
pubmed: 37461085
doi: 10.1186/s13019-023-02323-0
pii: 10.1186/s13019-023-02323-0
pmc: PMC10351123
doi:
Substances chimiques
Troponin I
0
Biomarkers
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
234Informations de copyright
© 2023. The Author(s).
Références
Ann Emerg Med. 2016 Jul;68(1):76-87.e4
pubmed: 26794254
Interact Cardiovasc Thorac Surg. 2014 May;18(5):544-50
pubmed: 24468543
Clin Chem. 2012 Jan;58(1):54-61
pubmed: 21965555
Eur Heart J Acute Cardiovasc Care. 2013 Dec;2(4):323-33
pubmed: 24338291
N Engl J Med. 2020 Jul 16;383(3):290
pubmed: 32668123
Eur Heart J. 2016 Jan 14;37(3):267-315
pubmed: 26320110
Anaesth Intensive Care. 2019 May;47(3):255-266
pubmed: 31165618
J Am Coll Cardiol. 2013 Oct 22;62(17):1563-70
pubmed: 24135581
N Engl J Med. 2022 Mar 3;386(9):827-836
pubmed: 35235725
Clin Chem. 2019 Mar;65(3):484-489
pubmed: 30626631
N Engl J Med. 2019 Nov 7;381(19):1820-1830
pubmed: 31562798
Circulation. 2019 Nov 5;140(19):1543-1556
pubmed: 31478763
Clin Cardiol. 1998 Sep;21(9):625-32
pubmed: 9755378
J Am Coll Cardiol. 2019 Jul 30;74(4):483-494
pubmed: 31345421
Clin Chem Lab Med. 2014 Nov;52(11):1657-65
pubmed: 24897400
Circulation. 2018 Jun 12;137(24):2635-2650
pubmed: 29891620
J Am Coll Cardiol. 2012 Dec 11;60(23):2427-63
pubmed: 23154053
Ann Thorac Surg. 2016 Jun;101(6):2202-8
pubmed: 26912303
Heart. 2011 May;97(10):810-6
pubmed: 21378388
Circulation. 2018 Nov 13;138(20):e618-e651
pubmed: 30571511
Eur Heart J. 2018 Apr 1;39(13):1100-1109
pubmed: 29365133
Eur Heart J. 2017 Aug 14;38(31):2392-2407
pubmed: 28821170
N Engl J Med. 2019 Jun 27;380(26):2529-2540
pubmed: 31242362
Glob Heart. 2012 Dec;7(4):275-95
pubmed: 25689940